Tomeko — every condition, connected. Open full hub →
Home  /  Disease hubs  /  Immune-mediated necrotizing myopathy

Immune-mediated necrotizing myopathy

Specialists and centers, recruiting clinical trials, patient organizations, research, and community for Immune-mediated necrotizing myopathy — brought together in one place.

Open the full interactive hub for Immune-mediated necrotizing myopathy →

Find specialists Clinical trials Patient organizations Research & market

Just diagnosed with Immune-mediated necrotizing myopathy?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Immune-mediated necrotizing myopathy, look for clinical trials, and connect with others living with it — all in one place.

Open the full interactive Immune-mediated necrotizing myopathy hub →

Overview

Immune-mediated necrotizing myopathy is a rare condition. Also known as AINM, Autoimmune necrotizing myositis, IMNM, NAM, Necrotizing autoimmune myositis. Tomeko brings together the specialists, research, clinical trials, treatments and community for Immune-mediated necrotizing myopathy so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:206569 · ICD-10 G72.4 · GARD 0020351

Find care for Immune-mediated necrotizing myopathy

Authoritative references for Immune-mediated necrotizing myopathy

Research & market landscape for Immune-mediated necrotizing myopathy

Following Immune-mediated necrotizing myopathy for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Immune-mediated necrotizing myopathy — the real-world landscape behind the condition, in one place.

Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Immune-mediated necrotizing myopathy and every rare condition. See how Tomeko works with industry →

Common questions

What is Immune-mediated necrotizing myopathy?

Immune-mediated necrotizing myopathy is a rare condition. Also known as AINM, Autoimmune necrotizing myositis, IMNM, NAM, Necrotizing autoimmune myositis. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Immune-mediated necrotizing myopathy together in one place.

What are the symptoms of Immune-mediated necrotizing myopathy?

Symptoms of Immune-mediated necrotizing myopathy vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Immune-mediated necrotizing myopathy.

How is Immune-mediated necrotizing myopathy treated?

Treatment for Immune-mediated necrotizing myopathy depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Immune-mediated necrotizing myopathy, and review current options with them.

What causes Immune-mediated necrotizing myopathy — is it genetic?

The cause and inheritance of Immune-mediated necrotizing myopathy are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Immune-mediated necrotizing myopathy can explain what it means for you and your family.

I was just diagnosed with Immune-mediated necrotizing myopathy — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Immune-mediated necrotizing myopathy, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Immune-mediated necrotizing myopathy?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Immune-mediated necrotizing myopathy, filtered to your area.

Are there clinical trials for Immune-mediated necrotizing myopathy?

Tomeko shows live, recruiting studies for Immune-mediated necrotizing myopathy from ClinicalTrials.gov on the hub.

Related conditions

Other conditions on Tomeko you may be looking for: